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Abstract 
Background. Although serial transverse enteroplasty (STEP) improves 
function of dilated short bowel, a significant proportion of patients require 
repeat surgery. To address underlying reasons for unsuccessful STEP, we 
compared small intestinal mucosal characteristics between initial and repeat 
STEP procedures in children with short bowel syndrome (SBS). 
Methods. Fifteen SBS children, who underwent 13 first and 7 repeat STEP 
procedures with full thickness small bowel samples at median age 1.5 years 
(IQR 0.7-3.7) were included. The specimens were analyzed histologically for 
mucosal morphology, inflammation and muscular thickness. Mucosal 
proliferation and apoptosis was analyzed with MIB1 and Tunel 
immunohistochemistry. 
Results. Median small bowel length increased 42% by initial STEP and 13% 
by repeat STEP (P=0.05), while enteral caloric intake increased from 6% to 
36% (P=0.07) during 14 (12-42) months between the procedures. Abnormal 
mucosal inflammation was frequently observed both at initial (69%) and 
additional STEP (86%, P=0.52) surgery. Villus height, crypt depth, enterocyte 
proliferation and apoptosis as well as muscular thickness were comparable at 
first and repeat STEP (P>0.05 for all). Patients, who required repeat STEP 
tended to be younger (P=0.057) with less apoptotic crypt cells (P=0.031) at 
first STEP. Absence of ileocecal valve associated with increased 
intraepithelial leukocyte count and reduced crypt cell proliferation index 
(P<0.05 for both). 
Conclusions. No adaptive mucosal hyperplasia or muscular alterations 
occurred between first and repeat STEP. Persistent inflammation and lacking 
mucosal growth may contribute to continuing bowel dysfunction in SBS 
children, who require repeat STEP procedure, especially after removal of the 
ileocecal valve. 
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Introduction 
Short bowel syndrome (SBS) is the most common cause of intestinal failure and 
persistent need for long-term parenteral nutrition (PN). SBS is frequently associated 
with serious complications including intestinal failure associated liver disease, septic 
episodes and loss of venous access sites  1. A subset of SBS patients develop 
abnormal dilatation of the remaining small intestine, which predicts prolonged PN 
dependence and decreased survival  2,3. Pathophysiology of adaptation-associated 
small bowel dilatation remains unclear, but underlying diagnosis of small intestinal 
atresia seems to be a major predisposing factor  2,3. Recent evidence suggest that 
excessive dilatation predisposes to mucosal damage and bowel-derived blood stream 
infections most likely secondary to increased mucosal inflammation and permeability  4,5. 
Autologous intestinal reconstruction (AIR) surgery including serial transverse 
enteroplasty (STEP) has been increasingly used to improve function of dilated small 
intestine by restoring normal bowel caliber with simultaneous increase in length  6-9. 
Unfortunately, 40%-80% of the patients require repeat surgery mainly due to small 
intestinal redilatation after initial STEP, representing the major functional drawback of 
this operation  10-14. The need for repeat STEP has been associated with absence of the 
ileocecal valve  13, suggesting that this anatomic region may regulate intestinal growth, 
motility and its loss promotes microbiota which allow recurrence of dilatation and 
adversely affects STEP outcomes. However, underlying reasons for unsuccessful STEP 
remain unclear, while no data on intestinal histology in these patients are available. To 
this end, we assessed histologic intestinal inflammation, mucosal morphology, 
enterocyte proliferation and apoptosis as well as muscular thickness in unique set of full 
thickness small bowel samples obtained from SBS children during initial and additional 
STEP procedures. 
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Methods 
Ethics 
The University of Michigan institutional review board (IRB nro HUM00063515) approved 
this study. An informed written consent for tissue stu dy was received from all patients 
and/or caregivers before any procedures. 
Patients 
A total of 26 STEP procedures were performed in Michigan Mott Children’s Hospital 
between 2003 and 2014. Indication for STEP procedure was abnormal small bowel 
dilatation combined with unprogressive weaning from PN. Patients with full thickness 
small intestinal samples obtained during STEP surgery for pathological analysis were 
included in the study. Bowel specimens were analyzed in Helsinki University Children’s 
Hospital. 
Patient background data, including gestational age and weight, etiology of SBS, length 
and anatomy of the remaining bowel, age at STEP procedures, pre- and post-STEP 
bowel length, percentage of total daily calories delivered in PN, and weaning off PN, 
were obtained from patient charts  10. Predicted small bowel length was estimated using 
an age based normogram  15. 
Small bowel histology and immunohistochemistry 
The samples were fixed in formalin, embedded in paraffin, sliced and stained with 
hematoxylin and eosin. For histologic analyses, the slices were first reviewed manually 
with Leica DM RXA microscope (Leica Microsystems GmbH, Wetzlar, Germany) and 
then photographed using ImageJ Image Analysis Software (SciJava Common open 
source software; Rasband, W.S., ImageJ, U.S. National Institutes of Health, Bethesda, 
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Maryland, USA; http://imagej.nih.gov/ij/; 1997–2014) by the primary researcher (AM) 
blinded to clinical data. Only well-oriented villi and crypts were chosen for analysis of 
mucosal morphology. Median of 10 (range 3-10) and 8 (range 3-10) representative villi 
and crypts were measured in each sample. Inflammation in the lamina propria was 
graded from 1 to 4 (grade 1 = few scattered inflammatory cells between crypts; 2 = 
moderate number of inflammatory cells distributed diffusely through the lamina propria, 
3 = large number of inflammatory cells often in combination with short or broad villi; 4 = 
intense infiltrate with short, broad or absent villi) 16,17. Abnormal inflammation was 
defined as ≥grade 2. Intraepithelial inflammation was assessed by counting intraepitelial 
leukocytes (IEL), including lymphocytes, eosinophiles and neutrophiles per 100 
enterocytes in three representative villi 18. Muscularis thickness was measured at three 
different representative locations of the sample.  
Immunohistochemistry included MIB1 for Ki-67 labeling index to analyze enterocyte 
proliferation and Tunel for analyzing enterocyte apoptosis. Immunostaining for MIB1 
was conducted with routine hospital laboratory protocol. Tunel staining was performed 
with Apoptosis Tunel assay Kit (APO-BrdU IHC™ Immunohistochemistry Kit, APO0002, 
BioRad Laboratories, California, USA) according to manufacturers instructions (dilution 
1:15). Overall MIB1 positivity was scored from 1 to 3 based on the location of positively 
stained enterocytes in crypt-villus axis (grade 1 = MIB1 positive cells in crypts; 2 = MIB1 
positive enterocytes in crypts and in the lower half of villi; 3 = MIB1 positive enterocytes 
in crypts and above the lower half of villi). In addition, MIB1 positive enterocytes were 
calculated in three representative villi and crypts and percentage of positive enterocytes 
was calculated. Overall Tunel staining was scored from 0 to 3 (grade 0 = only solitary 
positive nuclei in villi; 1 = clusters of positive nuclei in villi; 2 = villi diffusely covered with 
positive nuclei; 3 = positive nuclei in both villi and crypts) 19. In addition, Tunel positive 
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nuclei were calculated in three representative villi and crypt for calculation of percentage 
of positive cells. 
Statistics 
Data are expressed as median (IQR, interquartile range) or frequencies. Mann Whitney 
U test and Fisher exact test were used for between group comparisons. Correlations 
were analyzed with Spearman rank. P-value under 0.05 was considered statistically 
significant. 
 
Results 
Patient characteristics 
Altogether 15 SBS patients were included. Their baseline characteristics are shown in 
Table 1. The most common etiology of SBS was intestinal atresia with or without 
gastroschisis. Median small bowel length was 22 cm and only three (20%) had ileocecal 
valve remaining. 
The 15 patients underwent a total of 20 STEP procedures at median age 1.5 (0.7-3.7) 
years (Table 2). Median age difference between initial and repeat STEP procedure was 
14 months (12-42). Intestinal specimens were available from 13 patients at initial STEP 
and seven patients at repeat STEP (six second and 1 third). Five patients had samples 
obtained at both procedures. Average postoperative follow up from initial STEP was 36 
months. Intestinal specimens obtained during initial small bowel resection at median 
age 0.5 (0.2-0.5) years were available in four patients and were used as controls.  
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Small intestinal length increased 42% by first STEP and 13% by additional STEP (Table 
2). At first STEP median percentage of parenteral energy provision was 94%, which 
decreased to 64% by the time of additional STEP, reflecting increased enteral tolerance. 
Only one patient weaned off PN after first STEP while none of the patients weaned off 
after repeat surgery.  
Mucosal and muscular morphology 
There were no significant differences in mucosal morphology or muscular thickness 
between samples taken at first and additional STEP procedures (Table 3). Patient age 
correlated positively with villus height (r=0.600, P=0.005) and mucosal thickness 
(r=0.567, P=0.009). No other correlations between the study variables were observed 
(P>0.05 for all). 
Mucosal proliferation and apoptosis 
Indexes of enterocyte proliferation and apoptosis both in crypts and villi were 
comparable in samples obtained at initial and additional STEP procedures (Table 3, 
Figure 1). Importantly, patients without an ileocecal valve had lower crypt cell MIB1 
proliferation index [74% (59-83)] compared to patients with preserved ileocecal valve 
[90% (88-90), P=0.025] (Figure 2).  
Mucosal inflammation 
Abnormal inflammation was frequently and similarly observed both at initial and 
additional STEP procedure, without statistically significant difference between the 
groups (Table 3, Figure 1). The intraepithelial inflammatory cells consisted mainly of 
lymphocytes with occasional eosinophils in lamina propria (<10% of inflammatory cells). 
Villus atrophy was present in two initial STEP samples but in none of additional STEP 
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samples. Notably, patients without an ileocecal valve showed over two-fold higher 
intraepithelial leukocyte count [14 IEL/100 enterocytes (11-17)] compared to patients 
with preserved ileocecal valve [6.4 (3.1-6.4), P=0.023)] (Figure 3). 
Predictors of repeat STEP 
To address which factors at the time of first STEP predicted repeat surgery, patients 
who underwent only one STEP were compared to those who subsequently underwent 
repeat STEP (Table 4). These comparisons revealed that the patients, who required 
repeat surgery tended to be younger and had reduced crypt cell apoptosis index at the 
time of first STEP, while no differences in parenteral energy requirement or small bowel 
length were observed. At the time of first STEP, absolute and age-adjusted small bowel 
length correlated with crypt and villus enterocyte apoptosis index (r=0.791-0.658, 
P<0.05 for all correlations). 
Comparison between initial bowel resection and STEP 
Because no differences were observed between initial and additional STEP specimens, 
they were pooled for comparisons to samples obtained at initial bowel resection (Table 
5). These comparisons showed a significant increase in villus width and a significant 
decrease in frequency of villus atrophy after initial resection. In addition, villus height 
increased insignificantly by 58% after resection, while no changes were observed in 
indexes of mucosal proliferation or apoptosis. 
 
Discussion 
In this study we have for the first time characterized morphology, proliferation and 
inflammation of the small intestinal mucosa in SBS children undergoing STEP 
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procedures.  Our major findings suggest, that despite increased small intestinal length 
and improving enteral energy tolerance after initial STEP, no evidence of adaptive 
mucosal hyperplasia or muscular alterations were observed in patients who underwent 
unsuccessful STEP requiring repeat surgery and continuation of PN.  In addition, 
abnormal mucosal inflammation persisted after initial STEP, which may contribute to 
bowel dysfunction among those children, who require repeated tapering surgery. Finally, 
absence of the ileocecal valve was associated with increased mucosal inflammation 
and reduced crypt cell proliferation. 
In SBS with prolonged PN dependency STEP procedure is the most commonly 
performed autologous intestinal reconstruction surgery for bowel lengthening and 
tapering aimed to improve intestinal function and subsequent weaning off PN  6,9. 
Following first STEP between 30% and 88% of patients are weaned off PN  9. Outcomes 
after repeat STEP procedures are often worse, reported weaning off rates ranging 
between 0% and 55%  10,13,14,20. Though most patients in this study were not able to 
wean off PN after initial STEP procedure providing 42% increase in small bowel length, 
enteral energy tolerance had increased from 6% to 36% by the time of repeat STEP. 
Despite the moderate increase in enteral caloric tolerance, we did not find any 
differences in villus height, crypt depth, mucosal proliferation indexes or muscular 
thickness between the samples taken at first and additional STEP procedures. These 
observations suggest that no significant adaptive mucosal hyperplasia occurs after 
unsuccessful STEP in patients who require repeat procedure, and that the improved 
enteral tolerance may be mediated by other mechanisms such as beneficial changes in 
motility or age related bowel growth. Our findings differ from a previous study reporting 
increased plasma citrulline, a surrogate for mucosal mass, by 12 months after STEP in 
children  21 and an experimental study reporting increased villus height after STEP in 
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rats  22. Importantly, in the former clinical study seven of eight long-term survivors 
weaned off PN and none required repeat STEP for redilatation  21. Thus, whether 
adaptive mucosal hyperplasia occurs in patients who undergo successful STEP not 
necessitating repeat surgeries remains unclear. Indeed, abnormal small bowel dilatation 
has been shown to associate with decreased plasma citrulline levels, suggesting that 
excessive (re)dilatation may impair mucosal growth following STEP surgery 4. 
In the present study evidence of abnormal histologic mucosal inflammation persisted in 
patients, who required repeat STEP. Interestingly, absence of the ileocecal valve was 
associated with increased intraepithelial leukocyte infiltration and decreased crypt cell 
proliferation index. These findings are important, as intestinal mucosal inflammation and 
the lack of the ileocecal valve appears to have a central role in the pathophysiology of 
adaptation-associated small bowel dilatation and intestinal failure associated liver 
disease 4,23,24. Recent clinical studies suggest that absent ileocecal valve predicts the 
need for repeat STEP  13, while excessive adaptive small bowel dilatation is associated 
with intestinal inflammation, as measured by increased fecal calprotectin, and with 
bowel-derived blood stream infections, which seem to be instrumental in promoting 
hepatic inflammation and cholestasis  4,23,25. Excessive small bowel dilatation hampers 
propulsive intestinal motility, which may in turn predispose to unfavorable changes in 
intestinal microbiota, inflammation and increased epithelial permeability  4,5,26-28. 
Furthermore, tapering of excessive small intestinal dilatation significantly decreased 
fecal calprotectin concentration to the normal level among 17 patients of whom 71% 
weaned by 3.1 years after surgery, suggesting that successful STEP helps to 
ameliorate intestinal inflammation 29. Our present observations further indicate that in 
patients with unsuccessful first STEP and the need for repeated surgery histologic 
intestinal inflammation persists possibly contributing to unfavorable functional outcome 
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in this patient subgroup  10,14. Accordingly, in the present study none of the patients who 
underwent repeat STEP achieved enteral autonomy. 
Enhanced mucosal inflammation and decreased mucosal crypt cell proliferation as 
observed here after removal of the ileocecal valve, may reflect essential 
pathophysiological mechanisms explaining why absent ileocecal valve predisposes to 
repeat STEP  13. Surgical removal of the ileocecal region may promote uncontrolled 
proliferation of unfavorable colonic microbiota in the remaining small intestine after loss 
of compartmentalization between large and small bowel and adversely affect motility 
and mucosal growth by reducing secretion of several physiological enteroendocrine 
peptides such as glucagon like peptide 2  30. In addition to absent ileocecal valve, young 
age and reduced crypt cell apoptosis at first STEP seemed to associate with the need 
for repeat surgery, indicating that early STEP surgery may predispose to unfavorable 
outcome. Overall, these findings suggest that STEP should be postponed beyond the 
most active period of physiological adaptation. 
We acknowledge many limitations of this study, including lack of healthy controls, 
control group of IF patients able to wean off PN after STEP procedure, actual 
measurements of small bowel diameter and simultaneous assessment of intestinal 
microbiota. Due to retrospective study design we were also unable to relate specific 
individual operative indications with outcomes. Relatively small number of patients 
precluded meaningful subgroup analyses between different underlying etiologies of SBS. 
However, we believe that this study provides unique data helping to understand 
pathophysiology of failed tapering surgery in SBS. Future studies linking objectively 
measured intestinal dilatation with microbiota alterations and inflammation would be 
important. 
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In conclusion, no evidence of adaptive mucosal hyperplasia or muscular alterations was 
observed after unsuccessful STEP in patients who required repeat surgery. Persistent 
inflammation and lack of mucosal growth may contribute to continuing bowel 
dysfunction in SBS children, who require repeat STEP surgery, especially after removal 
of the ileocecal valve.  
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Figure legends 
Figure 1. Common histological findings related to multiple STEP procedures. A) 
inflammation grade 4 in lamina propria at the time of the second STEP procedure, 
10x magnification; B) villus atrophy at the time of the first STEP procedure, 10x 
magnification; C) MIB1 staining showing enterocyte proliferation in villi and crypts 
at the time of first STEP procedure, positive nuclei stained with brown, overall MIB1 
grade 3, crypt 100%, villi 24%, 10x magnification; D) Tunel staining showing 
apoptosis in enterocytes at the time of second STEP procedure, positive nuclei 
stained with brown, overall Tunel grade 3, villi 59%, crypt 61%, 10x magnification. 
Figure 2. Decreased MIB1 proliferation index (% of positive nuclei) in crypts in patients 
without ileocecal valve (ICV) compared to patients with preserved ICV. Mann Whitney U 
test between the two groups, P=0.025. 
Figure 3. Increased intraepithelial inflammation in patients without ileocecal valve (ICV) 
compared to patients with preserved ICV. Mann Whitney U test between the two groups, 
P=0.023. 
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Table 1. Patient characteristics 
Number of patients  15 
Birth weight (kg) 2.4 (2.0-3.0) 
Gestational age (wk) 34 (32-37) 
Parenteral nutrition dependency (n) 15 
Diagnosis (n)  
Gastroschisis with small bowel atresia 4 
Small bowel atresia 4 
Midgut volvulus 3 
Gastroschisis 2 
Necrotizing enterocolitis 2 
Bowel anatomy after initial resection  
Small bowel (cm) 22 (18-51) 
Small bowel (% of expected) 12 (7-19) 
< 10% of expected small bowel length (n) 5 
ICV present (n) 3 
Colon present (n) 15 
Data are median (interquartile range) or frequencies. 
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Table 2. Small bowel length and nutrition at intial and repeat STEP 
 
 Intial STEP Repeat 
STEP 
P-value* 
Number of patients  13 7  
Age (y) 1.0 (0.4-3.7) 1.9 (1.0-3.8) 0.219 
Small bowel length    
Pre-STEP (cm) 45 (30-85) 56 (45-80) 0.634 
Post-STEP (cm) 58 (42-100) 72 (56-102) 0.463 
Change (%) 42 (13-77) 13 (8-36) 0.051 
Change (cm) 17 (10-30) 12 (3-20) 0.261 
Ileocecal valve present (n) 3 0 0.263 
Parenteral energy requirement (%) 94 (67-100) 64 (62-81) 0.071 
Weaned off PN after STEP (n) 1 0 0.588 
 
Data are median (interquartile range) of frequencies. STEP; serial 
transverse enteroplasty, PN; parenteral nutrition. Mann Whitney U 
test or Fisher’s exact test, comparison between the two groups.  
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Table 3. Comparison of small bowel histology and mucosal proliferation 
indexes between specimen obtained at initial and repeat STEP 
 Initial STEP Repeat STEP P-value 
Number of patients 13 7  
Mucosal morphology    
Villus height (mm) 0.74 (0.46-1.02) 0.72 (0.64-0.75) 0.721 
Villus width  (mm) 0.27 (0.24-0.30) 0.31 (0.22-0.32) 0.663 
Villus atrophy (n) 2 0 0.521 
Crypt depth (mm) 0.44 (0.30-0.51) 0.42 (0.38-0.59) 0.552 
Mucosal thickness (mm) 1.4 (0.87-1.9) 1.8 (1.2-1.8) 0.405 
Muscularis thickness (mm) 2.7 (1.8-3.9) 2.9 (2.6-4.1) 0.483 
Inflammation    
Abnormal inflammation (n) 9 6 0.522 
Lamina propria, (1-4) 2.0 (1.0-3.0) 3.0 (2.0-3.0) 0.352 
IEL (/100 enterocytes) 14 (6.4-17) 12 (7.0-15) 0.618 
Proliferation     
Grade (1-3) 1 (1-2) 1 (1) 0.110 
Villus (% of positive nuclei) 4.6 (0-8.7) 5.9 (2.0-6.6) 0.656 
Crypt (% of positive nuclei) 79 (59-89) 71 (58-78) 0.219 
Apoptosis    
Grade (0-3) 1 (0-3) 1 (0-3) 1.000 
Villus (% of positive nuclei) 21 (1.0-38) 16 (0-56) 0.791 
Crypt (% of positive nuclei) 10 (0-41) 18 (0-46) 0.524 
Data are median (interquartile range) or frequencies. STEP; serial 
transverse enteroplasty, IEL; intraepithelial leukocytes. 
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Table 4. Comparison between patients with one and multiple STEP 
procedures at the time of first STEP procedure. 
 
At first STEP 
One STEP 
procedure 
Repeat STEP 
procedures 
 
P-value* 
Number of patients 7 6  
Age (y) 1.5 (0.9-7.9) 0.5 (0.1-1.7) 0.057 
PN energy requirement 
(%) 
89 (55-100) 100 (82-100) 0.386 
Small bowel length     
Pre-STEP (cm) 55 (34-104) 42 (25-83) 0.379 
Post-STEP (cm) 75 (45-103) 47 (34-89) 0.240 
Change (%) 60 (28-85) 24 (12-76) 0.336 
Change (cm) 22 (14-50) 12 (5.5-17) 0.086 
Mucosal morphology    
Villus height (mm) 0.73 (0.60-1.11) 0.74 (0.30-0.94) 0.464 
Villus Width (mm) 0.28 (0.24-0.33) 0.25 (0.21-0.28) 0.143 
Villus atrophy (n) 1 1 0.641 
Crypt depth (mm) 0.44 (0.29-0.52) 0.48 (0.26-0.54) 0.884 
Mucosal thickness (mm) 1.54 (0.82-1.98) 1.35 (0.87-1.76) 0.661 
Muscularis thickness (m) 3.21 (1.79-1.98) 2.5 (1.51-4.18) 0.770 
Inflammation    
Abnormal inflammation 
(n) 
6 3 0.745 
Lamina propria (1-4) 2.0 (1.3-2.8) 2.5 (1.25-3.0) 0.721 
IEL (/100 enterocytes) 14 (6.4-14) 14 (5.4-22) 0.850 
Proliferation     
Grade (1-3) 1.0 (1.0-1.8) 1.0 (10.-2.0) 0.584 
Villus (% of positive 
nuclei) 
4.1 (0.0-8.8) 4.6 (0.0-17) 1.000 
Crypt (% of positive 
nuclei) 
82 (61-89) 75 (45-95) 1.000 
Apoptosis     
Grade (0-3) 2.5 (0.0-3.0) 0.0 (0.0-1.5) 0.159 
Villus (% of positive 
nuclei) 
29 (4.3-45) 2.4 (0.0-23) 0.122 
Crypt (% of positive 
nuclei) 
26 (2.9-51) 0.0 (0.0-5.2) 0.031 
Data are median (interquartile range) or frequencies. STEP; serial transverse 
enteroplasty, PN; parenteral nutrition, IEL; intraepithelial leukocytes. Bowel 
specimens obtained at first STEP were available for 7 patients, who 
underwent one and for 5 patients who underwent repeated STEP procedure. 
*Mann Whitney U test or Fisher’s exact test, comparison between the two 
groups. 
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Table 5. Comparison of small bowel histology and mucosal proliferation 
indexes between specimen obtained at initial bowel resection and STEP 
Data are median (interquartile range) or frequencies. STEP; serial transverse 
enteroplasty, IEL; intraepithelial leukocytes.  
 Initial resection STEP P-value 
Number samples 4 20  
Age (y) 0.5 (0.2-0.5) 1.5 (0.7-3.7) 0.465 
Small bowel length (cm) 48 (16-64) 56 (38-80) 0.313 
Mucosal morphology    
Villus height (mm) 0.42 (0.39-1.0) 0.72 (0.60-0.95) 0.353 
Villus width  (mm) 0.18 (0.16-0.21) 0.27 (0.23-0.32) 0.005 
Villus atrophy (n) 3 2 0.006 
Crypt depth (mm) 0.47 (0.23-0.77) 0.44 (0.33-0.52) 0.877 
Mucosal thickness (mm) 1.1 (0.42-2.7) 1.5 (1.0-1.9) 0.588 
Muscularis thickness (mm) 2.4 (0.93-5.0) 2.9 (2.1-3.8) 0.746 
Inflammation    
Abnormal inflammation (n) 3 15 0.654 
Lamina propria (1-4) 2.5 (1.3-3.0) 2.0 (2.0-3.0) 0.966 
IEL (/100 enterocytes) 6.0 (3.3-9.1) 13 (6.9-16) 0.061 
Proliferation     
Grade (1-3) 1.0 (1.0-2.5) 1.0 (1.0) 0.661 
Villus (% of positive nuclei) 0 (0-29) 5.3 (0-8.3) 0.445 
Crypt (% of positive nuclei) 64 (46-84) 74 (59-88) 0.353 
Apoptosis    
Grade (0-3) 1.0 (0-2.8) 1.0 (0.0-3.0) 0.896 
Villus (% of positive nuclei) 13 (0-46) 21 (0-43) 0.742 
Crypt (% of positive nuclei) 13 (0-30) 12 (0-41) 0.735 
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